Cucoveica Oana, Stadoleanu Carmen, Bertsch Christelle, Triaud Romain, Condriuc Iustina Petra, Atanase Leonard Ionut, Delaite Christelle
"Cristofor Simionescu" Faculty of Chemical Engineering and Environmental Protection, "Gheorghe Asachi" Technical University of Iasi, 700050 Iasi, Romania.
Faculty of Medicine, Apollonia University of Iasi, 700511 Iasi, Romania.
Polymers (Basel). 2024 Sep 28;16(19):2748. doi: 10.3390/polym16192748.
Poly(L-lactic acid) (PLLA) and poly(ε-caprolactone) (PCL), two biodegradable and biocompatible polymers that are commonly used for biomedical applications, are, respectively, the result of the ring-opening polymerization of LA and ε-CL, cyclic esters, which can be produced according to several mechanisms (cationic, monomer-activated cationic, anionic, and coordination-insertion), except for L-lactide, which is polymerized only by anionic, cationic, or coordination-insertion polymerization. A series of well-defined PLLA-b-PCL block copolymers have been obtained starting from the same PLLA homopolymer, having a molar mass of 2500 g·mol, and being synthesized by coordination-insertion in the presence of tin octoate. PCL blocks were obtained via a cationic-activated monomer mechanism to limit transesterification reactions, and their molar masses varied from 1800 to 18,500 g·mol. The physicochemical properties of the copolymers were determined by H NMR, SEC, and DSC. Moreover, a series of nanoparticles (NPs) were prepared starting from these polyester-based copolymers by an emulsification/evaporation method. The sizes of the obtained NPs varied between 140 and 150 nm, as a function of the molar mass of the copolymers. Monomodal distribution curves with PDI values under 0.1 were obtained by Dynamic Light Scattering (DLS) and their spherical shape was confirmed by TEM. The increase in the temperature from 25 to 37 °C induced only a very slight decrease in the NP sizes. The results obtained in this preliminary study indicate that NPs have a temperature stability, allowing us to consider their use as drug-loaded nanocarriers for biomedical applications.
聚(L-乳酸)(PLLA)和聚(ε-己内酯)(PCL)是两种常用于生物医学应用的可生物降解且生物相容的聚合物,它们分别是环状酯L-丙交酯(LA)和ε-己内酯(ε-CL)开环聚合的产物,这两种环状酯可通过多种机制(阳离子、单体活化阳离子、阴离子和配位插入)制备,但L-丙交酯仅通过阴离子、阳离子或配位插入聚合进行聚合。从摩尔质量为2500 g·mol的同一PLLA均聚物出发,通过在辛酸亚锡存在下的配位插入合成,得到了一系列定义明确的PLLA-b-PCL嵌段共聚物。通过阳离子活化单体机制获得PCL嵌段以限制酯交换反应,其摩尔质量在1800至18500 g·mol之间变化。通过1H NMR、SEC和DSC测定了共聚物的物理化学性质。此外,从这些聚酯基共聚物出发,通过乳化/蒸发法制备了一系列纳米颗粒(NP)。所得NP的尺寸在140至150 nm之间变化,这是共聚物摩尔质量的函数。通过动态光散射(DLS)获得了PDI值低于0.1的单峰分布曲线,并通过TEM证实了它们的球形形状。温度从25℃升高到37℃仅导致NP尺寸非常轻微的减小。这项初步研究获得的结果表明,NP具有温度稳定性,这使我们能够考虑将其用作生物医学应用中载药纳米载体。